US EditionMicro Medical Solutions Expands Board of Directors with Appointment of Vince Burgess and John Dahldorf
Micro Medical Solutions adds two executives with extensive medical device and financial expertise to support FDA Premarket Approval and commercialization of MicroStent.
- Woburn, Mass.-based Micro Medical Solutions announced the appointments of Vince Burgess and John Dahldorf to its Board via PR Newswire, strengthening its leadership ahead of MicroStent's FDA review.
- Joining the MMS Board in November 2025, Vince Burgess brings experience as former President, CEO & Director of Acutus Medical and founding executive at Volcano Corporation, plus Venture Partner work at OrbiMed Advisors.
- The MicroStent, which has FDA Breakthrough Device Designation, is under Premarket Approval review as MMS advances toward commercialization, targeting improved blood flow and reduced amputations in CLTI patients.
- MMS said the new appointments will strengthen execution as the hires join George Quinoy, Chairman, President & Chief Executive Officer, and Dr. Ron Solar, Board Member, to bolster leadership for MicroStent commercialization.
- The company's market positioning coincides with board strengthening as Micro Medical Solutions describes itself at the intersection of clinical demand, regulatory momentum, and market opportunity, with appointees Vince Burgess and John Dahldorf reinforcing governance depth.
48 Articles
48 Articles
InsideNoVA.com
Micro Medical Solutions Expands Board of Directors with Appointment of Vince Burgess and John Dahldorf
WOBURN, Mass., Nov. 14, 2025 /PRNewswire/ -- Micro Medical Solutions (MMS), an innovative medical device company focused on improving outcomes for patients suffering from Critical Limb Threatening Ischemia (CLTI), today announced the appointment of Vince Burgess and John Dahldorf to…
Micro Medical Solutions Appoints Vince Burgess and John Dahldorf to Board
Micro Medical Solutions (MMS), an innovative medical device company focused on improving outcomes for patients suffering from Critical Limb Threatening Ischemia (CLTI), today announced the appointment of Vince Burgess and John Dahldorf to its Board of Directors. They join George Quinoy, Chairman of the Board and President & Chief Executive Officer, and Dr. Ron Solar, Board Member, as MMS strengthens its leadership team in preparation for commerc…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
